Overview

Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of linaclotide administered to patients with Irritable Bowel Syndrome with Constipation (IBS-C).
Phase:
Phase 3
Details
Lead Sponsor:
Ironwood Pharmaceuticals, Inc.
Collaborator:
Forest Laboratories
Treatments:
Linaclotide